Skip to content

Hinderk M. Emrich

10 papers in the library · 1,107 citations · publishing 1998-2012

Papers

Sort Most recent Most cited

Impaired perceptual processing and conceptual cognition in patients with anxiety disorders: A pilot study with the binocular depth inversion paradigm

Psychology Health & Medicine November 27, 2012 Torsten Passie, Udo Schneider, Mathias Borsutzky et al. 7 citations

The binocular depth inversion test (BDIT) measures a common illusion of visual perception whereby implausible objects are seen as normal, e.g., a hollow face is perceived as a normal, convex face. Such inversion is frequent, especially for objects with a high degree of familiarity. Under normal conditions, cognitive factors apparently override the binocular disparity cues of stereopsis. This...

Mitigation of post‐traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence

Drug Testing and Analysis June 26, 2012 Torsten Passie, Hinderk M. Emrich, Matthias Karst et al. 114 citations

It is known from clinical studies that some patients attempt to cope with the symptoms of post-traumatic stress disorder (PTSD) by using recreational drugs. This review presents a case report of a 19-year-old male patient with a spectrum of severe PTSD symptoms, such as intense flashbacks, panic attacks, and self-mutilation, who discovered that some of his major symptoms were dramatically...

The Pharmacology of Lysergic Acid Diethylamide: A Review

CNS Neuroscience & Therapeutics November 11, 2008 Torsten Passie, John H. Halpern, Dirk O. Stichtenoth et al. 459 citations

Lysergic acid diethylamide (LSD) was synthesized in 1938 and its psychoactive effects discovered in 1943. It was used during the 1950s and 1960s as an experimental drug in psychiatric research for producing so‐called “experimental psychosis” by altering neurotransmitter system and in psychotherapeutic procedures (“psycholytic” and “psychedelic” therapy). From the mid 1960s, it became an illegal...

Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness.

Schizophrenia Research December 1, 2006 Dagmar Koethe, Christoph W Gerth, Miriam A Neatby et al.

Recent data on alterations of the endogenous cannabinoid system in schizophrenia have raised the question of its functional role in this disease. The psychoactive compound of Cannabis sativa, delta-9-tetrahydrocannabinol (Delta9-THC), has been shown to induce psychotic symptoms, but it is unknown to what extend prodromal states of psychoses are reflected by these experimental approaches. This...

Effects of Different Subanesthetic Doses of (S)-Ketamine on Neuropsychology, Psychopathology, and State of Consciousness in Man

Neuropsychobiology 2005 Torsten Passie, Matthias Karst, Birgitt Wiese et al. 35 citations

This is the first neuropsychological study using the S-enantiomer of the noncompetitive N-methyl-D-aspartate antagonist ketamine. In 2 randomized placebo-controlled trials we studied effects of two different doses of (S)-ketamine (low dose/high dose) on neuropsychological functions and psychopathology in 12 healthy male volunteers. Impairment was measured via standardized neuropsychological...

Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in man

Journal of Psychopharmacology 2003 Torsten Passie, Matthias Karst, Mathias Borsutzky et al. 27 citations

The role of the N-methyl-D-aspartate (NMDA) neurotransmitter system in relation to psychoses is not completely understood, but represent a challenge in neurobiological research. The psychotic states induced by NMDA antagonists such as phencyclidine and ketamine have been described as being most similar to schizophrenia and the NMDA system has been implicated in the pathogenesis of...

The pharmacology of psilocybin

Addiction Biology October 1, 2002 Torsten Passie, Juergen Seifert, Udo Schneider et al. 465 citations

Abstract Psilocybin (4‐phosphoryloxy‐N,N‐dimethyltryptamine) is the major psychoactive alkaloid of some species of mushrooms distributed worldwide.These mushrooms represent a growing problem regarding hallucinogenic drug abuse. Despite its experimental medical use in the 1960s, only very few pharmacological data about psilocybin were known until recently. Because of its still growing capacity...

Different effects of nabilone and cannabidiol on binocular depth inversion in Man.

Pharmacology, biochemistry, and behavior May 2000 F M Leweke, U Schneider, M Radwan et al.

The physiological and pathophysiological roles of the central nervous endogenous cannabinoid system are not completely understood, but still represent a challenge in basic neurobiological, cognitive, and psychiatric research. The system has been implicated in the pathogenesis of schizophrenia. Binocular depth inversion, an illusion of visual perception, provides a model of impaired perception...

Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man.

Psychopharmacology March 1999 F M Leweke, U Schneider, M Thies et al.

Binocular depth inversion represents an illusion of visual perception that is sensitive to various behavioural and psychiatric conditions. It is affected by cannabinoids, reflecting associated changes in perception. The present study investigated the differences in binocular depth inversion of different classes of natural and artificial objects and the effect of synthetic...

Cannabinoid/anandamide system and schizophrenia: is there evidence for association?

Pharmacopsychiatry July 1998 U Schneider, F M Leweke, K R Mueller-Vahl et al.

Cognitive impairments during psychotic episodes are assumed to be caused not only by one single putative classical neurotransmitter dysfunction but also to be due to an impaired equilibrium of the interaction between different neurobiological generators of cognitive processes. Here, the perceptual abnormalities induced by psychotogenic agents play a major role as tools for understanding model...